Table 1.
DGAST and PNET patient demographics
| Identification | Clinical diagnosis | Age | MEN1 syndrome |
ZES | Mets | Tumour grade (WHO) |
Ki67 (%) | RNA-seq | WES |
| 87 | Duodenal gastrinoma | 43 | + | − | + | 1 | <1 | + | − |
| 215 | Duodenal gastrinoma | 32 | + | + | + | 2 | 10 | + | + |
| 219 | Duodenal gastrinoma | 70 | − | + | + | 2 | 12 | + | + |
| 269 | Duodenal gastrinoma | 57 | − | − | + | 1 | 2 | + | + |
| 290 | DNET | 50 | − | − | − | 1 | <2 | − | + |
| 48 | Gastrinoma PNET | 47 | + | + | + | 1 | n/a | − | + |
| 134 | VIPoma PNET | 50 | + | − | − | 1 | <2 | + | + |
| 136 | Non-functional PNET | 50 | − | − | − | 1 | 2 | + | + |
| 299 | Non-functional PNET | 67 | − | − | + | 2 | 7 | − | + |
| 358 | Non-functional PNET | 49 | − | − | − | 1 | 2 | + | − |
| 362 | Non-functional PNET | 47 | − | − | − | 1 | 2 | − | + |
| 371 | Non-functional PNET | 74 | − | − | + | 2 | 9 | + | − |
| 396 | Non-functional PNET | 63 | − | − | − | 2 | 6 | + | − |
| 401 | Glucagonoma PNET | 63 | − | − | − | 1 | <2 | + | − |
DGAST, duodenal gastrinoma; DNET, duodenal neuroendocrine tumour; MEN1, multiple endocrine neoplasia, type 1; Mets, Metastasis; n/a, not available; PNET, pancreatic neuroendocrine tumour; RNA-seq, RNA-sequencing; WES, whole exome sequencing; ZES, Zollinger-Ellison Syndrome.